INDV: Rasio kapitalisasi marang pendapatan Indivior plc

Simbol lan logo merek Indivior Group (INDV)

Indivior PLC dominates opioid addiction therapy through Sublocade, extracting superprofits from inelastic demand. The market cap-to-revenue ratio confirms this resilience, with the metric currently standing at 2.60. The company is building a comprehensive treatment environment by integrating medications with psychological support. The business is currently scaling long-acting injections while navigating legal complexities and generic pressure.

indivior.com (INDV): Kapitalisasi marang pendapatan saka 21.02.2024 nganti 13.11.2026

Rincian metrik lan analitis perusahaan Indivior Group (INDV)

- rega saham lan target rega konsensus:
Kurs saham indivior.com|INDV - Prakiraan konsensus analis
- informasi kapitalisasi pasar:
Kapitalisasi pasar Indivior Group|INDV - Nilai Perusahaan
- rincian valuasi buku bisnis:
Aset Bersih saben Saham Indivior|INDV - Aset Bersih Perusahaan|Rasio Nilai Pasar marang Nilai Buku indivior.com|INDV - Total Aset Perusahaan
- statistik kawajiban utang lan likuiditas:
Koefisien Total Utang marang Modal Indivior PLC|INDV - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal Indivior Corp|INDV - Utang perusahaan|Rasio utang marang aset resik Indivior Group|INDV - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Indivior|Rasio likuiditas kritis indivior.com
- data bathi resik lan rasio valuasi:
INDV - Bathi resik perusahaan|Bathi sing dikarepake Indivior PLC|INDV - Pangali P/E|Prakiraan rega marang bathi Indivior plc|INDV - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Indivior Group|INDV - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajrone 12 wulan pungkasan Indivior|INDV - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan indivior.com|INDV - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Indivior PLC
- indikator pendapatan dodolan lan penghasilan bisnis:
INDV - Pendapatan perusahaan|Prakiraan pendapatan perusahaan indivior.com|INDV - Multiplikator P/S|Multiplikator Forward P/S Indivior Group
Analisis fundamental perusahaan:indivior.com, INDV
Barang utama Indivior

Investors must evaluate the resilience of Indivior PLC to patent risks and the pace of portfolio diversification through the lens of the market value of one dollar of revenue. The current P/S multiple of 2.60 reflects the ratio of market capitalization to total sales, allowing for a determination of the asset's overvaluation relative to its actual ability to generate cash flow under intense legal pressure.

Karo sapa Indivior PLC saingan

collegiumpharma.com - Rasio kapitalisasi marang pendapatan|Multiplikator P/S CRON (Cronos Group)|CGC: Rasio kapitalisasi marang pendapatan|High Tide Corp - Multiplikator P/S|Koefisien rega marang pendapatan Aurora Cannabis ACB|ACHV (Achieve Life Sciences) - Kapitalisasi marang pendapatan|SKYE (skyebioscience.com) - Rasio rega marang pendapatan|ANEB (Anebulo Pharmaceuticals, Inc.) - Multiplikator P/S|Canndoc (INCR) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Nutriband Inc. (NTRB)|NSRX - Rega marang dodolan|Rasio rega marang pendapatan IGC Pharma IGC|Rasio kapitalisasi pasar marang pendapatan MIRA|FLGC: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan IMCC (IM Cannabis Corp.)|adialpharma.com (ADIL) - Rasio rega marang pendapatan|Rasio rega marang dodolan ARTL (Artelo Biosciences, Inc.)|Rasio rega marang pendapatan Ensysce Biosciences Inc.|Rasio rega marang pendapatan TTNP|Multiplikator P/S GNLN|Kapitalisasi marang pendapatan InMed Pharmaceuticals Inc INM|Multiplikator P/S AKAN (Akanda Corporation)|Koefisien rega marang pendapatan Enveric Corp (ENVB)|BGXX - Rasio rega marang pendapatan|HPCO (Hempacco Co Inc.) - Rasio kapitalisasi marang pendapatan